The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial registered on ANZCTR


Registration number
Help: Registration number
ACTRN12626000807358p
Ethics application status
Help: Ethics application status
Submitted, not yet approved
Date submitted
Help: Date submitted
21/04/2026
Date registered
Help: Date registered
6/07/2026
Date last updated
Help: Date last updated
6/07/2026
Date data sharing statement initially provided
Help: Data sharing statement date
6/07/2026
Type of registration
Help: Type of registration
Prospectively registered

Titles & IDs
Public title
Can use of the LipReader communication app improve communication in voiceless intensive care patients?
Scientific title
A prospective within-participant feasibility study of the LipReader app in voiceless intensive care unit patients, assessing communication effectiveness and usability
Additional trial identifiers [1] 317005 0
Nil
Universal Trial Number (UTN)
U1111-1339-2138
Trial acronym
Related trial records

Health condition
Health condition(s) studied:
critical illness myopathy 341547 0
Tracheostomy 341548 0
Acquired communication disorders 341549 0
Mechanical ventilation 341550 0
Dysphonia 341551 0
Dysarthria 341552 0
Cerebrovascular accident 341553 0
Traumatic brain injury 341554 0
Condition category
Condition code
Respiratory 337623 337623 0 0
Other respiratory disorders / diseases
Stroke 337624 337624 0 0
Ischaemic
Respiratory 337625 337625 0 0
Chronic obstructive pulmonary disease
Neurological 337626 337626 0 0
Neurodegenerative diseases
Mental Health 337627 337627 0 0
Depression
Physical Medicine / Rehabilitation 337628 337628 0 0
Speech therapy
Neurological 337630 337630 0 0
Multiple sclerosis
Injuries and Accidents 337631 337631 0 0
Other injuries and accidents

Intervention/exposure
Study type
Interventional
Description of the intervention or exposure

Arm 1: LipReader intervention

Participants will use LipReader during a single supervised study session conducted at the bedside in the intensive care unit or step-down setting. LipReader is a smartphone-based visual speech recognition application designed to support communication for individuals who are unable to use their voice. The application uses the device’s built-in front-facing camera to capture lip movements during silent speech and applies an artificial intelligence model to predict silently mouthed phrases, which are then presented as on-screen text and/or synthesised speech output. The system is designed for short, functional utterances relevant to bedside care and everyday patient needs.

For this Phase 1 study, LipReader will be used only under supervision of the research team and only for non-critical, functional communication. It is non-invasive, does not provide diagnostic or therapeutic advice, does not replace clinical judgement or standard communication pathways, and will not be used to support goals-of-care discussions or other high-stakes clinical decision-making. LipReader is used for research purposes only in this study.

Each participant will complete a brief, standardised orientation to LipReader and the comparator communication method before commencing the communication tasks. Participants will act as their own comparator by completing communication attempts using both LipReader and standard bedside communication tools during the same supervised session. All participants will complete the LipReader condition and the comparator condition in the same session. The order of communication methods will be standardised, with LipReader completed first followed by the comparator communication method. A short rest break of approximately 5 minutes will be offered between communication methods, or longer if required due to fatigue, distress or clinical care needs.

Participants will communicate a set of pre-agreed functional phrases. Each communication attempt will have an allocated time window of up to 2 minutes. The time from commencement of each communication attempt to correct identification of the participant’s intended message will be recorded. If the intended message is not correctly identified within the allocated time window, the attempt will be recorded as unsuccessful for that attempt.

The total study session will last approximately 20 to 30 minutes. If a session is interrupted by clinical care, fatigue or distress, the interruption will be documented and the session may be paused or terminated as clinically appropriate.

LipReader will be used on a research-owned, password-protected smartphone configured by the research team. Participants will not use personal devices, will not be required to log in or enter identifiable information, and no conversational content will be retained as part of the clinical record. Adherence will be monitored directly by the research team during the single study session.
Intervention code [1] 333801 0
Treatment: Other
Intervention code [2] 334513 0
Treatment: Devices
Description of the comparator or control
Comparator/control:

The comparator is one standard bedside communication tool currently used in routine care. This may include an alphabet chart or pen-and-paper. Participants will not be required to use every standard communication tool listed. The comparator tool will be selected by the researcher in consultation with the participant and bedside staff, based on the participant’s physical abilities, fatigue level, communication needs and usual care approach.

During the single supervised study session, participants will communicate a set of pre-agreed functional phrases using both LipReader and the selected standard bedside communication tool in a within-participant comparison design. The comparator will be delivered individually at the bedside in the intensive care unit or step-down setting, with support from the research team and usual bedside staff as required. Each communication attempt will have an allocated time window of up to 2 minutes. The total session will last approximately 20 to 30 minutes. No additional adherence procedures are required beyond direct supervision during the study session.
Control group
Active

Outcomes
Primary outcome [1] 345116 0
Time to understand successful message understanding
Timepoint [1] 345116 0
During the single study session, immediately following each communication attempt using LipReader and standard communication tools
Secondary outcome [1] 460537 0
Message success rate
Timepoint [1] 460537 0
During the single study session, immediately following each communication attempt
Secondary outcome [2] 460538 0
Number of repetitions required
Timepoint [2] 460538 0
During the single study session, immediately following each communication attempt
Secondary outcome [3] 460539 0
Patient usability ratings
Timepoint [3] 460539 0
Immediately following completion of the study session
Secondary outcome [4] 460540 0
Nurse usability and perceived workload
Timepoint [4] 460540 0
Immediately following the study session or at the end of the clinical shift
Secondary outcome [5] 460541 0
Time required for orientation and training
Timepoint [5] 460541 0
At the beginning of the single study session

Eligibility
Key inclusion criteria
• Adults aged 18 years or older
• Currently voiceless due to tracheostomy, prolonged intubation or related airway management
• Clinically stable and suitable for participation at the time of the study session
• Able to tolerate a brief communication interaction
• Able to demonstrate capacity to provide informed consent
• Able to demonstrate reliable yes/no communication
• Able to participate in a brief communication task using LipReader and standard communication tools
Minimum age
18 Years
Maximum age
No limit
Sex
Both males and females
Healthy volunteers
No
Key exclusion criteria
• Inability to demonstrate capacity to provide informed consent
• Inconsistent or unreliable yes/no responses
• Delirium or acute cognitive impairment
• Clinical instability requiring urgent intervention
• Severe visual impairment preventing use of the smartphone interface
• Facial obstruction preventing adequate lip visibility
• Distress, fatigue or discomfort making participation inappropriate
• Any circumstance in which the treating team considers participation not to be in the patient’s best interests

Study design
Purpose of the study
Treatment
Allocation to intervention
Non-randomised trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Masking / blinding
Blinded (masking used)
Who is / are masked / blinded?


The people assessing the outcomes
Intervention assignment
Crossover
Other design features
Phase
Not Applicable
Type of endpoint/s
Safety/efficacy
Statistical methods / analysis
This is a pilot feasibility and usability study. Analyses will be descriptive and exploratory rather than confirmatory. Continuous outcomes such as time to successful message understanding will be summarised using mean and standard deviation or median and interquartile range depending on data distribution. Categorical outcomes such as message success rate will be summarised as proportions with 95% confidence intervals. Within-participant comparisons between LipReader and standard communication tools will be described. Exploratory paired statistical tests may be used where appropriate, including paired t-tests or Wilcoxon signed-rank tests. Qualitative feedback will be analysed thematically. The study is not powered for definitive efficacy conclusions.

Recruitment
Recruitment status
Not yet recruiting
Date of first participant enrolment
Anticipated
Actual
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
Actual
Sample size
Target
Accrual to date
Final
Recruitment in Australia
Recruitment state(s)
WA
Recruitment hospital [1] 29402 0
Fiona Stanley Hospital - Murdoch
Recruitment postcode(s) [1] 45723 0
6150 - Murdoch

Funding & Sponsors
Funding source category [1] 321603 0
Self funded/Unfunded
Name [1] 321603 0
internal/in-house SMHS support
Country [1] 321603 0
Australia
Primary sponsor type
Government body
Name
South Metropolitan Health Service
Address
Country
Australia
Secondary sponsor category [1] 324458 0
None
Name [1] 324458 0
Address [1] 324458 0
Country [1] 324458 0
Other collaborator category [1] 283908 0
University
Name [1] 283908 0
Edith Cowan University
Address [1] 283908 0
Country [1] 283908 0
Australia

Ethics approval
Ethics application status
Submitted, not yet approved
Ethics committee name [1] 320129 0
WA Health Central HREC
Ethics committee address [1] 320129 0
Ethics committee country [1] 320129 0
Australia
Date submitted for ethics approval [1] 320129 0
23/06/2026
Approval date [1] 320129 0
Ethics approval number [1] 320129 0
RGS0000008375

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 149530 0
Mr Jason Hall
Address 149530 0
Fiona Stanley Hospital, South Metro Health Service, 11 Robin Warren Dr, Murdoch WA 6150
Country 149530 0
Australia
Phone 149530 0
+61 426760804
Fax 149530 0
Email 149530 0
Contact person for public queries
Name 149531 0
Jason Hall
Address 149531 0
Fiona Stanley Hospital, South Metro Health Service, 11 Robin Warren Dr, Murdoch WA 6150
Country 149531 0
Australia
Phone 149531 0
+61426760804
Fax 149531 0
Email 149531 0
Contact person for scientific queries
Name 149532 0
Nicholas Anthony
Address 149532 0
Fiona Stanley Hospital, South Metro Health Service, 11 Robin Warren Dr, Murdoch WA 6150
Country 149532 0
Australia
Phone 149532 0
+61 8 6152 6545
Fax 149532 0
Email 149532 0

Data sharing statement
Will the study consider sharing individual participant data?
No


What supporting documents are/will be available?

No Supporting Document Provided


Results publications and other study-related documents

Documents added manually
No documents have been uploaded by study researchers.

Documents added automatically
No additional documents have been identified.